LENZ THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Jul 25 · Aug 25 · Sep 25)
Total Assets
$306M
↑+42.1% +$91Mvs FY2024
Total Liabilities
$22M
↑+92.0% +$10Mvs FY2024
Equity
$284M
↑+39.3% +$80Mvs FY2024
Cash
$25M
↑+24.9% +$5Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $306M | $215M |
| Current Assets | $301M | $212M |
| Cash | $25M | $20M |
| ST Investments | $0 | $0 |
| Receivables | $329K | $0 |
| Inventory | $3M | $0 |
| Other Current | $273M | $192M |
| Non-Current Assets | $4M | $3M |
| PPE | $1M | $651K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $3M | $3M |
| Total Liab+Eq | $306M | $215M |
| Current Liab. | $21M | $10M |
| Accounts Payable | $4M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $17M | $6M |
| Non-Current Liab. | $350K | $814K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $350K | $814K |
| Equity | $284M | $204M |
| Retained Earnings | $227M | $145M |
| Other Equity | $57M | $59M |
QuarterCharts · SEC EDGAR data · LENZ · Comparing FY2025 vs FY2024